newsfilter
← Latest News
GlobeNewswire·

Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous